Nucleosidi

3'-Azido-2',3'-dideoxyuridine is an analog of the nucleoside dideoxyuridine that inhibits HIV replication. It has a high inhibitory dose and low toxicity. 3'-Azido-2',3'-dideoxyuridine is converted to its active form, 3'-azido-2',3'-dideoxythymidine (AZT), by dephosphorylation in human serum. AZT inhibits HIV replication by competing with the natural substrate for viral DNA polymerase, thereby inhibiting synthesis of viral DNA. 3'-Azido-2',3'-dideoxyuridine has been shown to be effective against hepatitis B virus and hepatitis C virus in cell cultures.

4'-C-Azido-2'-deoxy-2'-fluoro-b-D-arabinouridine is a novel nucleoside analog that can be activated to the monophosphate form for incorporation into DNA. It has antiviral and anticancer properties. 4'-C-Azido-2'-deoxy-2'-fluoro-b-D-arabinouridine has been shown to inhibit the proliferation of cultured tumor cells, suggesting a potential use in cancer chemotherapy.

4',5'-Didehydro-5'-deoxy-2'-O-methyluridine is a novel nucleoside phosphoramidite. It is a monophosphate, high purity and high quality. 4',5'-Didehydro-5'-deoxy-2'-O-methyluridine is an activator of DNA polymerase and can be used in the synthesis of DNA. 4',5'-Didehydro-5'-deoxy-2'-O-methyluridine also has antiviral properties and can be used to synthesize deoxyribonucleosides. It has been modified to have a diphosphate group at the 5' end, which allows it to be incorporated into DNA during synthesis.

2'-Deoxy-2',2'-difluorouridine 5'-triphosphate triethylammonium salt is a synthetic nucleoside which is an activator of deoxyribonucleoside monophosphates and diphosphates. This compound has antiviral, anticancer and antimicrobial properties. It is a novel nucleoside that has not been previously reported. This product is high purity, high quality, and CAS No.

2’,3’,5’-Tri-O-(tert-butyldimethylsilyl)-adenosine is a novel nucleoside that is synthetically modified by the replacement of the ribose sugar with an amino sugar. The modification of the sugar reduces the likelihood of hydrolysis to ribose and phosphate. This product has shown anticancer effects against human tumor cells in vitro and in vivo. It also has antiviral activities against herpes simplex virus type 1 (HSV-1). 2’,3’,5’-Tri-O-(tert-butyldimethylsilyl)-adenosine is a monophosphate nucleoside that inhibits DNA synthesis by inhibiting DNA polymerase. It acts as a competitive inhibitor for deoxyribonucleotides and phosphoramidites, which are used in DNA synthesis. 2’,3’,5’-

5-Bromo-2,4-di(benzyloxy)pyrimidine is an activator of DNA and RNA synthesis. It is a phosphoramidite that is used in the synthesis of oligonucleotides. 5-Bromo-2,4-di(benzyloxy)pyrimidine has antiviral activity and can inhibit the replication of HIV in vitro. This compound also has anticancer activity when it is given as a monophosphate, while its diphosphate form inhibits DNA and RNA synthesis. 5-Bromo-2,4-di(benzyloxy)pyrimidine can be synthesized from 2,4-dibenzyloxy pyrimidine and bromine in high purity with a CAS number 41244-53-5.

2-Amino-6-chloro-4-methoxypyrimidine (2ACMP) is a molecule that has been synthesized by the process of asymmetric synthesis. It is soluble in ethyl formate and has shown to be a strong inhibitor of the enzyme uv absorption, with an inhibition constant of 1.0 x 10 M. 2ACMP has been shown to inhibit molecular processes such as vibrational excitation, molecular modeling, and surface methodology. This molecule also binds to metal hydroxides and can be used for process optimization when combined with solubility data and nutrient solutions.

6-Azathymidine is an antiviral agent that prevents the synthesis of viral DNA. It is a nucleoside analogue that contains a hydroxyl group at the 6 position on a pyrimidine ring. This compound has been shown to be effective in treating HIV infection and cancer, as well as herpes simplex virus and influenza virus. 6-Azathymidine inhibits the enzyme ribonucleotide reductase, which is responsible for converting ribonucleotides into deoxyribonucleotides, thereby blocking DNA synthesis. The phosphate derivatives of this drug have been shown to inhibit the biosynthesis of human immunodeficiency virus (HIV) by interfering with intermolecular hydrogen bonding between guanine and adenine.